InvestorsHub Logo
Followers 6
Posts 1377
Boards Moderated 0
Alias Born 12/23/2017

Re: Drugdoctor post# 20871

Wednesday, 01/03/2024 3:38:57 PM

Wednesday, January 03, 2024 3:38:57 PM

Post# of 21347
I don't subscribe to Punchbowl, but this has a bit more of a write up on it.
https://www.marijuanamoment.net/dea-tells-congress-it-has-final-authority-on-marijuana-regardless-of-health-agencys-schedule-iii-recommendation/

Scheduling change is not assured. Logically it's a no brainer, but the no brainers running the show, including congressional leaders and even ex-DEA staff are arguing against that move. A more interesting article would be one on what the true motivations are for their position of being against.

The DEA reviewing is nice to know, but the review needs to end positively by aligning to the HHS recommendation at the least, but as the DEA strongly states, it's the DEA's call. What that will be no one knows, and all guesses are meaningless. I think MJ remains with little interest until that review is done, and hopefully, when it is done, it's not a kiss of death for the sector.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SHWZ News